These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 9000814

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Use of selective thalamotomy for various kinds of movement disorder, based on basic studies.
    Ohye C.
    Stereotact Funct Neurosurg; 2000; 75(2-3):54-65. PubMed ID: 11740171
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Idiopathic oromandibular dyskinesia treated by Vo complex microstereotactic thalamotomy.
    Narabayashi H, Yokochi F, Nakajima Y.
    Appl Neurophysiol; 1985; 48(1-6):309-14. PubMed ID: 3915654
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of etybenzatropine and diazepam on levodopa-induced diphasic dyskinesias in Parkinson's disease.
    Pourcher E, Bonnet AM, Kefalos J, Dubois B, Agid Y.
    Mov Disord; 1989; 4(3):195-201. PubMed ID: 2779590
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Onset-and end-of-dose dyskinesias induced by L-dopa treatment in a patient with juvenile parkinsonism].
    Katsuki T, Shimizu N, Mizuno Y.
    No To Shinkei; 1984 Dec; 36(12):1201-5. PubMed ID: 6529518
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment.
    Crossman AR.
    Mov Disord; 1990 Dec; 5(2):100-8. PubMed ID: 1970120
    [Abstract] [Full Text] [Related]

  • 14. Subthalamic nucleus stimulation improves directly levodopa induced dyskinesias in Parkinson's disease.
    Figueiras-Méndez R, Marín-Zarza F, Antonio Molina J, Jiménez-Jiménez FJ, Ortí-Pareja M, Magariños C, López-Pino MA, Martínez V.
    J Neurol Neurosurg Psychiatry; 1999 Apr; 66(4):549-50. PubMed ID: 10201440
    [No Abstract] [Full Text] [Related]

  • 15. Levodopa infusion does not decrease the onset of abnormal involuntary movements in parkinsonian rats.
    Papathanou M, van der Laan R, Jenner P, Rose S, McCreary AC.
    Mov Disord; 2013 Jul; 28(8):1072-9. PubMed ID: 23125107
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nighttime levodopa infusions to treat motor fluctuations in advanced Parkinson's disease: preliminary observations.
    Sage JI, Mark MH.
    Ann Neurol; 1991 Oct; 30(4):616-7. PubMed ID: 1789688
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Isoniazid therapy in Parkinson's disease.
    Gershanik OS, Luquin MR, Scipioni O, Obeso JA.
    Mov Disord; 1988 Oct; 3(2):133-9. PubMed ID: 3221901
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.